We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Popular Inc
BPOP
$11.3B
| $2.41M | 0.01% |
69,991
+1,040
| +2% | +$34.4K |
|
1277
Brady Corp
BRC
$4.62B
| $2.4M | 0.01% |
84,742
+450
| +0.5% | +$12.2K |
|
|
GES
1278
DELISTED
Guess Inc
GES
| $2.39M | 0.01% |
128,787
+6,970
| +6% | +$132K |
|
|
TBRG
1279
DELISTED
TruBridge
TBRG
| $2.39M | 0.01% |
44,119
+8,600
| +24% | +$471K |
|
1280
Integra LifeSciences
IART
$1.38B
| $2.39M | 0.01% |
94,904
+5,444
| +6% | +$129K |
|
1281
Methode Electronics
MEI
$612M
| $2.39M | 0.01% |
50,821
+5,410
| +12% | +$216K |
|
1282
Sabra Healthcare REIT
SBRA
$5.32B
| $2.39M | 0.01% |
72,109
+13,160
| +22% | +$427K |
|
|
ARGO
1283
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.39M | 0.01% |
60,203
+163
| +0.3% | +$6.33K |
|
1284
Huron Consulting
HURN
$2.38B
| $2.39M | 0.01% |
36,069
+700
| +2% | +$49.1K |
|
|
FCH
1285
DELISTED
Felcor Lodging Trust
FCH
| $2.39M | 0.01% |
207,688
+4,725
| +2% | +$50.9K |
|
1286
Children's Place
PLCE
$58M
| $2.38M | 0.01% |
37,057
-160
| -0.4% | -$9.64K |
|
|
MDCO
1287
DELISTED
Medicines Co
MDCO
| $2.38M | 0.01% |
84,915
+8,315
| +11% | +$234K |
|
1288
Enviri
NVRI
$647M
| $2.37M | 0.01% |
137,516
+17,475
| +15% | +$288K |
|
|
HPY
1289
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $2.37M | 0.01% |
50,673
+4,640
| +10% | +$235K |
|
|
KW
1290
DELISTED
Kennedy-Wilson Holdings
KW
| $2.37M | 0.01% |
90,646
+3,600
| +4% | +$95.4K |
|
|
DMC
1291
Del Monte Corp
DMC
$1.4B
| $2.36M | 0.01% |
60,698
+1,600
| +3% | +$56K |
|
|
GEVA
1292
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $2.36M | 0.01% |
24,195
+4,941
| +26% | +$523K |
|
|
MDC
1293
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.36M | 0.01% |
114,825
+4,182
| +4% | +$80.1K |
|
1294
Capitol Federal Financial
CFFN
$1.12B
| $2.35M | 0.01% |
188,140
+5,425
| +3% | +$68K |
|
1295
BWX Technologies
BWXT
$15.4B
| $2.35M | 0.01% |
102,391
-1,099
| -1% | -$23.1K |
|
|
FNSR
1296
DELISTED
Finisar Corp
FNSR
| $2.35M | 0.01% |
110,098
+21,165
| +24% | +$431K |
|
|
EQC
1297
DELISTED
Equity Commonwealth
EQC
| $2.35M | 0.01% |
88,420
+1,500
| +2% | +$39.4K |
|
|
SDRL
1298
DELISTED
Seadrill Limited Common Stock
SDRL
| $2.35M | 0.01% |
937
-61
| -6% | -$177K |
|
1299
Kaiser Aluminum
KALU
$2.91B
| $2.34M | 0.01% |
30,490
-1,550
| -5% | -$114K |
|
|
DYAX
1300
DELISTED
DYAX CORPORATION
DYAX
| $2.34M | 0.01% |
139,707
+24,525
| +21% | +$382K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.